Eslicarbazepine Acetate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67877-588 -
Package NDC
67877-588-30 -
Application number
ANDA211199 -
SPL ID
ca4bcb9f-157d-4d49-92f5-6b76745aabe1 -
SPL set ID
28efe9d2-9d7b-4a7c-8458-098456d06604 -
UNII
BEA68ZVB2K -
RxCUI
1482507 -
RxCUI
1482515 -
RxCUI
1482521 -
RxCUI
1482525
What the source publishes
- Labeler
- Ascend Laboratories, LLC
- Active ingredients
- Eslicarbazepine Acetate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Eslicarbazepine Acetate",
"splId": "ca4bcb9f-157d-4d49-92f5-6b76745aabe1",
"labels": [
{
"setId": "28efe9d2-9d7b-4a7c-8458-098456d06604",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=28efe9d2-9d7b-4a7c-8458-098456d06604",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28efe9d2-9d7b-4a7c-8458-098456d06604"
}
],
"routes": [
"ORAL"
],
"labeler": "Ascend Laboratories, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (67877-588-30)",
"package_ndc": "67877-588-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20250506"
}
],
"productId": "67877-588_ca4bcb9f-157d-4d49-92f5-6b76745aabe1",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "67877-588",
"deaSchedule": null,
"genericName": "Eslicarbazepine Acetate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ESLICARBAZEPINE ACETATE",
"strength": "800 mg/1"
}
],
"applicationNumber": "ANDA211199",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250506",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0367877588308",
"0367877586304",
"0367877585307"
],
"unii": [
"BEA68ZVB2K"
],
"rxcui": [
"1482507",
"1482515",
"1482521",
"1482525"
],
"spl_set_id": [
"28efe9d2-9d7b-4a7c-8458-098456d06604"
],
"manufacturer_name": [
"Ascend Laboratories, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67877-588_ca4bcb9f-157d-4d49-92f5-6b76745aabe1"